Pancreatic Cancer Research

ResearcherShanghaiTech UniversityNo recent work listed

Wei Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3711-5181; OpenAlex author ID A5031091204. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

  1. OX40L-Armed Oncolytic Virus Boosts T-cell Response and Remodels Tumor Microenvironment for Pancreatic Cancer Treatment. Co-author DOI 10.7150/thno.83495↗
  2. The JNK Signaling Pathway Is a Novel Molecular Target for S-Propargyl- L-Cysteine, a Naturally-Occurring Garlic Derivatives: Link to Its Anticancer Activity in… Co-author DOI 10.2174/1568009615666150602143943↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuan Wang · 1 shared paper, 2023 · strength 0.13
  2. Wenrui Gao · 1 shared paper, 2023 · strength 0.13
  3. Mingjuan Du · 1 shared paper, 2023 · strength 0.13
  4. Shiyu Liu · 1 shared paper, 2023 · strength 0.13
  5. Youjia Cao · 1 shared paper, 2023 · strength 0.13
  6. Hongkai Zhang · 1 shared paper, 2023 · strength 0.13
  7. Ruikun Wang · 1 shared paper, 2023 · strength 0.13
  8. Yi Zhun Zhu · 1 shared paper, 2015 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.